ABI
MNKD icon

Adamant Biomedical Investments’s MannKind Corp MNKD Stock Holding History

Adamant Biomedical Investments’s Portfolio MNKD Stock Details MNKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.56M Hold
60,000
– – 0.37% 74
2014
Q3 		$1.77M Buy
+60,000
New +$2.37M 0.44% 65

Other funds holding MNKD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Adamant Biomedical Investments's MNKD Position: Q4 2014 in Review

Adamant Biomedical Investments held its MannKind Corp (MNKD) position steady in Q4 2014 at 60,000 shares worth $1.56M. The position accounts for 0.37% of the portfolio, ranked #74.

Adamant Biomedical Investments first reported a position in MNKD in Q3 2014 and has held it in 2 quarters since. The position peaked at $1.77M in Q3 2014. 180 funds tracked by Wall St. Rank hold MNKD as of Q4 2014.

  • Adamant Biomedical Investments held 60,000 shares of MannKind Corp worth $1.56M as of Q4 2014.
  • Adamant Biomedical Investments left its MannKind Corp share count unchanged in Q4 2014.
  • MannKind Corp made up 0.37% of Adamant Biomedical Investments's portfolio in Q4 2014, its #74 holding.
  • Adamant Biomedical Investments first reported a position in MannKind Corp in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's MannKind Corp position peaked at $1.77M in Q3 2014.
  • 180 funds tracked by Wall St. Rank held MannKind Corp as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.